Characterizing human pluripotent-stem-cell-derived vascular cells for tissue engineering applications

Stem Cells and Development

Volumn 24, Issue 4, 2015, Pages 451-458

  Kusuma, Sravanti ^a,b   Facklam, Amanda ^b   Gerecht, Sharon ^a,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Johns Hopkins University   (United States)

^c Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; COLLAGEN TYPE 1; COLLAGEN TYPE 4; FIBRONECTIN; LAMININ; OXYGEN; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL CULTURE; STEM CELL EXPANSION; TISSUE ENGINEERING; ANGIOGENESIS; ANIMAL; CELL LINE; CYTOLOGY; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM;

ANGIOPOIETIN-1; ANIMALS; CELL DIFFERENTIATION; CELL LINE; COLLAGEN TYPE IV; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; TISSUE ENGINEERING;

EID: 84923113204     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0377     Document Type: Article

References (33)

1. Bae H, AS Puranik, R Gauvin, F Edalat, B Carrillo-Conde, NA Peppas and A Khademhosseini. (2012). Building vascular networks. Sci Transl Med 4:160.
2. Leeper NJ, AL Hunter and JP Cooke. (2010). Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 122:517-526.
3. Kusuma S and S Gerecht. (2010). Engineering blood vessels using stem cells: innovative approaches to treat vascular disorders. Expert Rev Cardiovasc Ther 8:1433-1445.
4. Samuel R, L Daheron, S Liao, T Vardam, WS Kamoun, A Batista, C Buecker, R Schafer, X Han, et al. (2013). Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proc Natl Acad Sci U S A 110:12774-12779.
5. Dar A and J Itskovitz-Eldor. (2013). Therapeutic potential of perivascular cells from human pluripotent stem cells. J Tissue Eng Regen Med [Epub ahead of print]: DOI: 10.1002/term.1698.
6. Wanjare M, S Kusuma and S Gerecht. (2013). Perivascular cells in blood vessel regeneration. Biotechnol J 8:434-447.
7. Kusuma S, Y-I Shen, D Hanjaya-Putra, P Mali, L Cheng and S Gerecht. (2013). Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix. Proc Natl Acad Sci U S A 110:12601-12606.
8. Davis GE and DR Senger. (2008). Extracellular matrix mediates a molecular balance between vascular morphogenesis and regression. Curr Opin Hematol 15:197-203.
9. Dickinson LE, S Kusuma and S Gerecht. (2011). Reconstructing the differentiation niche of embryonic stem cells using biomaterials. Macromol Biosci 11:36-49.
10. Heydarkhan-Hagvall S, M Esguerra, G Helenius, R Soderberg, BR Johansson and B Risberg. (2006). Production of extracellular matrix components in tissue-engineered blood vessels. Tissue Eng 12:831-842.
11. Rupert T. (1996). Macromolecular organization of basement membranes. Curr Opin Cell Biol 8:618-624.
12. Madri JA. (1997). Extracellular matrix modulation of vascular cell behaviour. Transpl Immunol 5:179-183.
13. Phelps EA and AJ Garcia. (2009). Update on therapeutic vascularization strategies. Regen Med 4:65-80.
14. Risau W and I Flamme. (1995). Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91.
15. Zisch AH, MP Lutolf and JA Hubbell. (2003). Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12:295-310.
16. Armulik A, A Abramsson and C Betsholtz. (2005). Endothelial/ pericyte interactions. Circ Res 97:512-523.
17. Orlidge A and PA DAmore. (1987). Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105:1455-1462.
18. Dar A, H Domev, O Ben-Yosef, M Tzukerman, N Zeevi- Levin, A Novak, I Germanguz, M Amit and J Itskovitz- Eldor. (2011). Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb/clinical perspective. Circulation 125:87-99.
19. Melero-Martin JM, ZA Khan, A Picard, X Wu, S Paruchuri and J Bischoff. (2007). In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109:4761-4768.
20. Feng Q, S-J Lu, I Klimanskaya, I Gomes, D Kim, Y Chung, GR Honig, K-S Kim and R Lanza. (2010). Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28:704-712.
21. Robinton DA and GQ Daley. (2012). The promise of induced pluripotent stem cells in research and therapy. Nature 481:295-305.
22. Kusuma S and S Gerecht. (2013). Recent progress in the use of induced pluripotent stem cells in vascular regeneration. Expert Rev of Cardiovasc Ther 11:661-663.
23. Chou BK, P Mali, X Huang, Z Ye, SN Dowey, LMS Resar, C Zou, YA Zhang, J Tong and L Cheng. (2011). Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res 21:518-529.
24. Cheng L, NF Hansen, L Zhao, Y Du, C Zou, FX Donovan, B-K Chou, G Zhou, S Li, et al. (2012). Low Incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression. Cell Stem Cell 10:337-344.
25. Kusuma S, E Peijnenburg, P Patel and SGerecht. (2014). Low oxygen tension enhances endothelial fate of human pluripotent stem cells. Arterioscler Thromb Vasc Biol 34:913-920.
26. Kusuma S, S Zhao and S Gerecht. (2012). The extracellular matrix is a novel attribute of endothelial progenitors and of hypoxic mature endothelial cells. FASEB J 26:4925-4936.
27. Wanjare M, S Kusuma and S Gerecht. (2014). Defining differences among perivascular cells derived from human pluripotent stem cells. Stem Cell Reports 2:561-575.
28. Pham I, T Uchida, C Planes, LB Ware, R Kaner, MA Matthay and C Clerici. (2002). Hypoxia upregulates VEGF expression in alveolar epithelial cells in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 283:L1133-L1142.
29. James D, HS Nam, M Seandel, D Nolan, T Janovitz, M Tomishima, L Studer, G Lee, D Lyden, et al. (2010). Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFB inhibition is Id1 dependent. Nat Biotechnol 28:161-166.
30. Hielscher A, C Qiu, J Porterfield, Q Smith and S Gerecht. (2013). Hypoxia affects the structure of breast cancer cellderived matrix to support angiogenic responses of endothelial cells. J Carcinog Mutagen 13:005.
31. Kiefer FN, H Berns, TJ Resnik and EJ Battegay. (2002). Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling. FASEB J 16:771-780.
32. Cooley LS, MM Handsley, Z Zhou, MA Lafleur, CJ Pennington, EW Thompson, E Pöschl and DR Edwards. (2010). Reversible transdifferentiation of blood vascular endothelial cells to a lymphatic-like phenotype in vitro. J Cell Sci 123:3808-3816.
33. Israely E, M Ginsberg, D Nolan, BS Ding, D James, O Elemento, S Rafii and SY Rabbany. (2014). Akt suppression of TGFb signaling contributes to the maintenance of vascular identity in embryonic stem cell-derived endothelial cells. Stem Cells 32:177-190.